121 related articles for article (PubMed ID: 16174176)
1. Breast magnetic resonance imaging: an essential role in malignant axillary lymphadenopathy of unknown origin.
McMahon K; Medoro L; Kennedy D
Australas Radiol; 2005 Oct; 49(5):382-9. PubMed ID: 16174176
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging for axillary staging in patients with breast cancer.
Mortellaro VE; Marshall J; Singer L; Hochwald SN; Chang M; Copeland EM; Grobmyer SR
J Magn Reson Imaging; 2009 Aug; 30(2):309-12. PubMed ID: 19466713
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis.
Varadarajan R; Edge SB; Yu J; Watroba N; Janarthanan BR
Oncology; 2006; 71(5-6):456-9. PubMed ID: 17690561
[TBL] [Abstract][Full Text] [Related]
4. Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy.
Black D; Specht M; Lee JM; Dominguez F; Gadd M; Hughes K; Rafferty E; Smith B
Ann Surg Oncol; 2007 Sep; 14(9):2477-84. PubMed ID: 17587091
[TBL] [Abstract][Full Text] [Related]
5. Impact of breast MRI on surgical treatment, axillary approach, and systemic therapy for breast cancer.
Mameri CS; Kemp C; Goldman SM; Sobral LA; Ajzen S
Breast J; 2008; 14(3):236-44. PubMed ID: 18476882
[TBL] [Abstract][Full Text] [Related]
6. MRI in the detection and management of breast cancer.
Padhani AR; Ah-See ML; Makris A
Expert Rev Anticancer Ther; 2005 Apr; 5(2):239-52. PubMed ID: 15877522
[TBL] [Abstract][Full Text] [Related]
7. Axillary metastatic disease as presentation of occult or contralateral breast cancer.
Lanitis S; Behranwala KA; Al-Mufti R; Hadjiminas D
Breast; 2009 Aug; 18(4):225-7. PubMed ID: 19656680
[TBL] [Abstract][Full Text] [Related]
8. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?
McLaughlin SA; Stempel M; Morris EA; Liberman L; King TA
Cancer; 2008 Mar; 112(6):1214-21. PubMed ID: 18257089
[TBL] [Abstract][Full Text] [Related]
9. Preoperative axillary staging in breast cancer-saving time and resources.
Tahir M; Osman KA; Shabbir J; Rogers C; Suarez R; Reynolds T; Bucknall T
Breast J; 2008; 14(4):369-71. PubMed ID: 18540958
[TBL] [Abstract][Full Text] [Related]
10. Role of pre-surgical breast MRI in the management of invasive breast carcinoma.
Del Frate C; Borghese L; Cedolini C; Bestagno A; Puglisi F; Isola M; Soldano F; Bazzocchi M
Breast; 2007 Oct; 16(5):469-81. PubMed ID: 17433681
[TBL] [Abstract][Full Text] [Related]
11. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
[TBL] [Abstract][Full Text] [Related]
12. Preoperative breast magnetic resonance imaging in early breast cancer: implications for partial breast irradiation.
Tendulkar RD; Chellman-Jeffers M; Rybicki LA; Rim A; Kotwal A; Macklis R; Obi BB
Cancer; 2009 Apr; 115(8):1621-30. PubMed ID: 19224552
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of fine needle aspiration cytology (FNAC) of axillary lymph nodes as a triage test in breast cancer staging.
Ciatto S; Brancato B; Risso G; Ambrogetti D; Bulgaresi P; Maddau C; Turco P; Houssami N
Breast Cancer Res Treat; 2007 May; 103(1):85-91. PubMed ID: 17033920
[TBL] [Abstract][Full Text] [Related]
14. Breast magnetic resonance imaging characteristics in women with occult primary breast carcinoma.
Lieberman S; Sella T; Maly B; Sosna J; Uziely B; Sklair-Levy M
Isr Med Assoc J; 2008 Jun; 10(6):448-52. PubMed ID: 18669145
[TBL] [Abstract][Full Text] [Related]
15. 'Occult' breast cancer.
Lloyd MS; Nash AG
Ann R Coll Surg Engl; 2001 Nov; 83(6):420-4. PubMed ID: 11777139
[TBL] [Abstract][Full Text] [Related]
16. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer.
Buchanan CL; Morris EA; Dorn PL; Borgen PI; Van Zee KJ
Ann Surg Oncol; 2005 Dec; 12(12):1045-53. PubMed ID: 16244803
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
18. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation.
Al-Hallaq HA; Mell LK; Bradley JA; Chen LF; Ali AN; Weichselbaum RR; Newstead GM; Chmura SJ
Cancer; 2008 Nov; 113(9):2408-14. PubMed ID: 18823018
[TBL] [Abstract][Full Text] [Related]
20. Lymph node axillary metastasis from occult contralateral infiltrating lobular carcinoma arising in accessory breast: MRI diagnosis.
Capobianco G; Spaliviero B; Dessole S; Rocca PC; Cherchi PL; Ambrosini G; Meloni F; Meloni GB
Breast J; 2007; 13(3):305-7. PubMed ID: 17461909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
